Carl Schoellhammer

@CMBS6

Startegy consultant and investor in biotech with @decibio, @mit alum, biotech founder @suonobio

Los Angeles, CA decibio.com Joined July 2014

230 Following 235 Followers 318 Posts

Latest posts 5

Carl Schoellhammer @CMBS6 May 16, 2023

Looking forward to connecting with friends new and old at #ASGCT23

DeciBio @DeciBio May 15, 2023

Hot off the press in time for attending #ASGCT23. We updated our manufacturing landscape for #celltherapy

Read more about it on our website: lnkd.in/g68rptxg

#cellmanufacturing #biotechnews #celltherapy #therapeutics #drugdiscovery #precisionmedicine

View quoted post on X

Carl Schoellhammer @CMBS6 Nov 22, 2022

got to chat #siRNA and #oligos with @juneatsirnagen Want to see where the #therapeutics field will go? have a read and find out!

#strategyconsulting #therapeutics #genetherapy

decibio.com/insights/the-b…

www.decibio.com The Broadening Use of siRNA in the Clinic: DeciBio's Q&A with June Park, CEO of siRNAgen Therapeu... Read our lastest Q&A with June Park, CEO of siRNAgen, a novel RNAi platform spun out of Korea-based Bioneer

Carl Schoellhammer @CMBS6 Jan 5, 2022

Making #RNA #medicines more broadly applicable will take new #delivery technologies. @SuonoBio 's platform for formulation-agnostic delivery of #oligos may do just that!

businesswire.com/news/home/2022…

www.businesswire.com Suono Bio, Inc. Announces Formulation-Agnostic Platform for the Delivery of RNA Therapeutics Suono Bio, Inc., the company revolutionizing the treatment of gastrointestinal diseases, today announced its latest publication in the Journal of Pharmaceuti...

Carl Schoellhammer @CMBS6 Jan 3, 2022

Official #predictions2022 for the #cellandgenetherapy field. Have a look and let us know what you think will happen #biotech #celltherapy #genetherapy #oligonucleotides decibio.com/insights/2022-…

www.decibio.com 2022 Cell and Gene Therapy Field Predictions With record investment going into next-generation therapies, we take stock of the field and make our predictions for what 2022 will bring for gene and cell therapies.

Carl Schoellhammer @CMBS6 Jul 20, 2021

Great writeup by @ZachinBoston @MIT on the power of #ultrasound for #drugdelivery and how @SuonoBio might enable the use of #nucleicacids and #DNA and #RNA drugs more broadly. #IBD
news.mit.edu/2021/suono-bio…

news.mit.edu Enhancing drug delivery with ultrasound Suono Bio, co-founded by MIT alumnus Carl Schoellhammer and two MIT professors, uses ultrasound waves to deliver drugs to the gastrointestinal tract, leveraging research made in MIT labs over more...